Regulatory 2020-07-31 | Change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2020-06-30 | Ascelia Pharma completes a directed new share issue of 4,697,781 shares, raising approximately SEK 98.7 million PDF Report Presentation Webcast
Regulatory 2020-05-20 | Updated SPARKLE timelines due to Covid-19 impact PDF Report Presentation Webcast
Regulatory 2020-05-13 | Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE PDF Report Presentation Webcast
Regulatory 2020-05-06 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 6 May 2020 PDF Report Presentation Webcast
Regulatory 2020-05-06 | First participant enrolled in the clinical hepatic impairment study with Mangoral PDF Report Presentation Webcast
Regulatory 2020-04-06 | Ascelia Pharma publishes Annual Report for the financial year 2019 PDF Report Presentation Webcast
Regulatory 2020-04-03 | Ascelia Pharma’s Nomination Committee proposes election of Lauren Barnes to the Board of Directors PDF Report Presentation Webcast
Regulatory 2020-04-03 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB PDF Report Presentation Webcast
Regulatory 2020-04-01 | Correction to press release regarding in change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2020-03-31 | Change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2020-03-02 | Issue and repurchase of series C shares for share saving program PDF Report Presentation Webcast
Regulatory 2020-02-19 | First patient enrolled in pivotal Phase III clinical study SPARKLE with lead candidate Mangoral PDF Report Presentation Webcast
Regulatory 2020-02-14 | 2019 year-end financial report: Sites opened for recruitment to the pivotal Phase III study SPARKLE PDF Report Presentation Webcast
Regulatory 2019-12-18 | Nomination Committee appointed for AGM 2020 in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2019-12-06 | Ascelia Pharma appoints Julie Waras Brogren as Chief Commercial Officer PDF Report Presentation Webcast
Regulatory 2019-11-14 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 14 November 2019 PDF Report Presentation Webcast
